6.4, and 5.1 Hz, 1Ј-H), 0.24 (1 H, ddd, J 9.6, 5.2, and 3.6 Hz, 3Ј-
Hcis), 0.35 (1 H, ddd, J 8.0, 6.4, and 3.6 Hz, 3Ј-Htrans), 0.55
(1 H, dddd, J 8.0, 7.4, 5.2 and 5.1 Hz, 2Ј-H), 1.21 (3 H, s, Me),
1.34 (3 H, s, Me), 2.92 (6 H, s, OMe), 3.32 (1 H, ddd, J 7.8, 7.4
and 6.0 Hz, 4Љ-H), 3.42 (1 H, dd, J 7.8 and 7.8 Hz, 5Љ-Ha), 3.86
(1 H, dd, J 7.8 and 6.0 Hz, 5Љ-Hb), 5.17 (2 H, s, 4-H and 5-H),
7.16–7.29 (20 H, m, ArH); δC (125 MHz; CDCl3) Ϫ2 (br, C-1Ј),
7.6 (C-3Ј), 19.4 (C-2Ј), 25.6 (Me), 26.8 (Me), 51.7 (OMe), 69.0
(C-5Љ), 77.7 (C-4/C-5), 80.0 (C-4Љ), 83.3 (CPh2OMe), 108.7
(C-2Љ), 127.1 (Ar), 127.4 (Ar), 127.5 (Ar), 127.7 (Ar), 128.3
(Ar), 129.7 (Ar), 141.2 (Ar), 141.4 (Ar).
Compound 22 (second eluted): mp 130 ЊC; [α]D Ϫ75.1 (c 1.10
in CHCl3); NMR δH (500 MHz; CDCl3) Ϫ0.68 (1 H, ddd, J 9.9,
6.1, and 5.5 Hz, 1Ј-H), 0.11 (1 H, ddd, J 7.5, 6.2, and 3.7 Hz,
3Ј-Htrans), 0.33 (1 H, ddd, J 9.9, 5.0, and 3.7 Hz, 3Ј-Hcis), 0.81
(1 H, dddd, J 8.4, 7.5, 5.5 and 5.0 Hz, 2Ј-H), 1.20 (3 H, s, Me),
1.30 (3 H, s, Me), 2.92 (6 H, s, OMe), 3.26 (1 H, ddd, J 8.4, 7.4
and 6.1 Hz, 4Љ-H), 3.63 (1 H, dd, J 7.8 and 7.8 Hz, 5Љ-Ha), 3.82
(1 H, dd, J 7.8 and 6.0 Hz, 5Љ-Hb), 5.20 (2 H, s, 4-H and 5-H),
7.19–7.25 (20 H, m, ArH); δC (125 MHz; CDCl3) Ϫ2 (br, C-1Ј),
9.8 (C-3Ј), 19.7 (C-2Ј), 25.6 (Me), 26.8 (Me), 51.7 (OMe), 69.2
(C-5Љ), 77.5 (C-4/C-5), 81.2 (C-4Љ), 83.3 (CPh2OMe), 108.9
(C-2Љ), 127.3 (Ar), 127.3 (Ar), 127.5 (Ar), 127.8 (Ar), 128.4
(Ar), 129.7 (Ar), 141.2 (Ar), 141.2 (Ar).
isolated in 69% yield as a 60:40 mixture; general procedure
D: yield 60% (dr 95:5), colourless oil. The diastereoisomers 25
and 26 could not be separated and fully purified; all data were
obtained from the mixtures. IR (film)/cmϪ1 2982, 2935, 1380
and 1067; m/z (EI, AUTO-CI) 269.1928 [(M ϩ H)ϩ. C14H26BO4
requires 269.1924]; 269 (25%) and 253 (100).
Compound 25: NMR δH (500 MHz; CDCl3) Ϫ0.28 (1 H,
ddd, J 9.8, 6.3, and 5.4 Hz, 1Ј-H), 0.67 (1 H, ddd, J 9.8, 5.0, and
3.7 Hz, 3Ј-Hcis), 0.79 (1 H, ddd, J 7.6, 6.3, and 3.7 Hz, 3Ј-
Htrans), 1.13 (1 H, complex m, 2Ј-H), 1.18 (12 H, br s, 4 × Me),
1.31 (3 H, s, Me), 1.41 (3 H, s, Me), 3.38 (1 H, dddd, J 8.4, 7.2,
6.1 and 1.2 Hz, 4Љ-H), 3.67 (1 H, dd, J 8.2 and 7.2 Hz, 5Љ-Ha),
4.03 (1 H, dd, J 8.2 and 6.1 Hz, 5Љ-Hb); δC (125 MHz; CDCl3)
Ϫ3.5 (br, C-1Ј), 9.2 (C-3Ј), 19.9 (C-2Ј), 24.6 (4 × Me), 25.7
(Me), 26.8 (Me), 69.6 (C-5Љ), 81.1 (C-4Љ), 83.1 (2 × Me2CO),
109.0 (C-2Љ).
Compound 26: NMR δH (500 MHz; CDCl3) Ϫ0.02 (1 H,
ddd, J 9.8, 6.3, and 5.1 Hz, 1Ј-H), 0.54 (1 H, ddd, J 9.8, 5.1, and
3.7 Hz, 3Ј-Hcis), 0.63 (1 H, ddd, J 8.0, 6.3, and 3.7 Hz,
3Ј-Htrans), 1.11–1.16 (1 H, m, 2Ј-H), 1.17 (6 H, s, 2 × Me), 1.18
(6 H, s, 2 × Me), 1.23 (3 H, s, Me), 1.38 (6 H, s, Me), 3.51
(1 H, ddd, J 7.5, 6.0 and 6.0 Hz, 4Љ-H), 3.64 (1 H, dd, J 8.0 and
7.5 Hz, 5Љ-Ha), 4.01 (1 H, dd, J 8.0 and 6.0 Hz, 5Љ-Hb); δC (125
MHz; CDCl3) Ϫ1.5 (br, C-1Ј), 7.4 (C-3Ј), 19.5 (C-2Ј), 24.5
(4 × Me), 24.7 (Me), 25.8 (Me), 69.2 (C-5Љ), 80.3 (C-4Љ), 83.0
(2 × Me2CO), 108.9 (C-2Љ).
(4S,5S,1ЈR,2ЈR,4ЉS)-2-[2-(2,2-Dimethyl-1,3-dioxolan-4-yl)cyclo-
propyl]-4,5-bis(methoxydiphenylmethyl)-1,3,2-dioxaborolane
(23) and (4S,5S,1ЈS,2ЈS,4ЉS)-2-[2-(2,2-dimethyl-1,3-dioxolan-4-
yl)cyclopropyl]-4,5-bis(methoxydiphenylmethyl)-1,3,2-dioxa-
borolane (24)
(1ЈR,2ЈR,4ЉS)-[2-(2,2-dimethyl-1,3-dioxolan-4-yl)cyclopropyl]-
methanol (27)
Cyclopropylboronic ester 25 (287 mg, 1.00 mmol) and chloro-
iodomethane (0.15 mL, 2.00 mmol) were dissolved in tetra-
hydrofuran and the solution cooled to Ϫ78 ЊC. Butyllithium
(1.25 mL of a 1.6 M solution in hexane, 2.00 mmol) was slowly
added, the reaction mixture warmed up to room temperature
and stirred for 2 d. A 1:1 mixture of 30% hydrogen peroxide
and 3 M aqueous sodium hydroxide (5 mL) was carefully added
and stirring continued until TLC indicated complete consump-
tion of the intermediate. Dilution with diethyl ether (10 mL)
was followed by the addition of a saturated aqueous ammo-
nium chloride solution (5 mL). After extraction of the aqueous
layer, drying with magnesium sulfate and evaporation of the
organic solvents under reduced pressure, the crude product was
subjected to flash-column chromatography (petroleum ether–
ethyl acetate 4:1 to 1:1). Yield 67% (dr >95:5), colourless oil.
The spectroscopic data were in full agreement with published
data.42 [α]D Ϫ13 (c 1.7 in CHCl3); IR (film)/cmϪ1 3424, 2987,
1372 and 1064; m/z (EI, AUTO-CI) 173.1172 [(M ϩ 1)ϩ.
C9H16O3 requires 173.1178]; 173 (15%) and 157 (100); NMR
δH (500 MHz; CDCl3) 0.53 (1 H, ddd, J 8.3, 5.1, and 5.0 Hz,
3Ј-Htrans), 0.60 (1 H, ddd, J 8.5, 5.1, and 5.0 Hz, 3Ј-Hcis), 0.84
(1 H, dddd, J 8.3, 7.8, 5.1, and 4.3 Hz, 2Ј-H), 0.99 (1 H, ddddd,
J 8.5, 6.9, 6.8, 5.1, and 4.3 Hz, 1Ј-H), 1.27 (3 H, s, Me), 1.37
(3 H, s, Me), 1.79 (1 H, br s, OH), 3.40 (1 H, dd, J 11.2 and 6.9
Hz, 1-Ha), 3.46 (1 H, dd, J 11.2 and 6.8 Hz, 1-Hb), 3.57 (1 H,
ddd, J 7.8, 7.2, and 5.9 Hz, 4Љ-H), 3.64 (1 H, dd, J 8.0 and 7.2
Hz, 5Љ-Ha), 4.04 (1 H, dd, J 8.0 and 5.9 Hz, 5Љ-Hb); δC (125
MHz; CDCl3) 7.9 (C-3Ј), 17.8 (C-3Ј), 19.0, 19.1 (C-1Ј/C-2Ј),
25.6 (Me), 26.7 (Me), 65.8 (C-1), 69.1 (C-5Љ), 79.0 (C-4Љ), 108.02
(C-2Љ).
Following the general procedure C, the product 23/24 was isol-
ated in 95% yield as a 50:50 mixture; general procedure D:
yield 72% (dr 94:6), white foam (Found: C, 75.18; H, 7.07.
C38H41BO6 requires C, 75.50; H, 6.84%); IR (film)/cmϪ1 3058,
2937, 1370 and 1076; m/z (EI) 604.2996 [(M)ϩ. C38H41BO6
requires 604.2996]; 604 (0.1%), 572 (0.1) and 197 (100). The
diastereoisomers 23 and 24 were separated by means of MPLC
(2% ethyl acetate in petroleum ether).
Compound 23 (second eluted): mp 120 ЊC; [α]D 40.0 (c 1.00 in
CHCl3); NMR δH (500 MHz; CDCl3) Ϫ0.68 (1 H, ddd, J 9.8,
6.3, and 5.4 Hz, 1Ј-H), 0.40 (1 H, ddd, J 9.8, 5.0, and 3.6 Hz, 3Ј-
Hcis), 0.48 (1 H, ddd, J 7.5, 6.3, and 3.6 Hz, 3Ј-Htrans), 0.59
(1 H, dddd, J 8.1, 7.5, 5.4 and 5.0 Hz, 2Ј-H), 1.21 (3 H, s, Me),
1.32 (3 H, s, Me), 2.92 (6 H, s, OMe), 3.16 (1 H, ddd, J 8.1, 7.2
and 6.1 Hz, 4Љ-H), 3.49 (1 H, dd, J 8.0 and 7.2 Hz, 5Љ-Ha), 3.86
(1 H, dd, J 8.0 and 6.1 Hz, 5Љ-Hb), 5.20 (2 H, s, 4-H and 5-H),
7.16–7.25 (20 H, m, ArH); δC (125 MHz; CDCl3) Ϫ4 (br, C-1Ј),
9.4 (C-3Ј), 19.5 (C-2Ј), 25.6 (Me), 26.8 (Me), 51.7 (OMe), 69.3
(C-5Љ), 77.6 (C-4/C-5), 80.9 (C-4Љ), 83.3 (CPh2OMe), 108.8
(C-2Љ), 127.3 (Ar), 127.3 (Ar), 127.5 (Ar), 127.8 (Ar), 128.4
(Ar), 129.7 (Ar), 141.3 (Ar), 141.3 (Ar).
Compound 24 (first eluted): mp 100–102 ЊC; [α]D 88.3 (c 1.00
in CHCl3); NMR δH (500 MHz; CDCl3) Ϫ0.51 (1 H, ddd,
J 10.0, 6.2, and 5.6 Hz, 1Ј-H), Ϫ0.04 (1 H, ddd, J 8.0, 6.2, and
3.6 Hz, 3Ј-Htrans), 0.21 (1 H, ddd, J 10.0, 5.2, and 3.6 Hz,
3Ј-Hcis), 0.79 (1 H, complex m, 2Ј-H), 1.20 (3 H, s, Me), 1.25
(3 H, s, Me), 2.93 (6 H, s, OMe), 3.36–3.38 (2 H, m, 4Љ-H and
5Љ-Ha), 3.82–3.84 (1 H, m, 5Љ-Hb), 5.17 (2 H, s, 4-H and 5-H),
7.16–7.27 (20 H, m, ArH); δC (125 MHz; CDCl3) Ϫ2 (br, C-1Ј),
7.7 (C-3Ј), 19.9 (C-2Ј), 25.6 (Me), 26.7 (Me), 51.7 (OMe),
68.8 (C-5Љ), 77.5 (C-4/C-5), 79.5 (C-4Љ), 83.2 (CPh2OMe), 108.6
(C-2Љ), 127.2 (Ar), 127.4 (Ar), 127.5 (Ar), 127.7 (Ar), 128.3
(Ar), 129.7 (Ar), 141.2 (Ar), 141.3 (Ar).
Acknowledgements
Financial support by the Fonds der Chemischen Industrie
(Liebig-fellowship for J. P.) and the Deutschen Forschungsge-
meinschaft (fellowship for J. P.) is gratefully acknowledged.
We also thank the Institut für Organische Chemie der
Universität Stuttgart (Professor Dr Dr h. c. F. Effenberger
and Professor Dr V. Jäger), the Bayer AG (Wuppertal), Aventis
Pharma Deutschland GmbH (Frankfurt/Main), Novartis AG
(Basel), the Boehringer Ingelheim KG (Biberach), the Degussa
(1ЈR,2ЈR,4ЉS)-2-[2-(2,2-Dimethyl-1,3-dioxolan-4-yl)cyclo-
propyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (25) and
(1ЈS,2ЈS,4ЉS)-2-[2-(2,2-dimethyl-1,3-dioxolan-4-yl)cyclopropyl]-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (26)
Following the general procedure C, the product 25/26 was
J. Chem. Soc., Perkin Trans. 1, 2000, 4293–4300
4299